Investigating genetic and biological markers for Sudden Infant Death Syndrome (SIDS)
Using Integrative Omics as Biomarkers and Diagnostic Tools for SIDS
This study is looking at the genetic clues that might help us understand why some babies are at risk for Sudden Infant Death Syndrome (SIDS), so we can find ways to keep infants safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10686407 on NIH RePORTER |
What this research studies
This research focuses on Sudden Infant Death Syndrome (SIDS), which is a leading cause of death in infants aged 1 month to 1 year. The project aims to identify genetic and epigenetic factors that may contribute to SIDS by analyzing liver, heart, and blood samples from infants who have died from this condition. By employing advanced genomic technologies, the researchers will look for specific biomarkers that could help predict which infants are at higher risk for SIDS. This comprehensive approach may lead to better understanding and prevention strategies for this tragic condition.
Who could benefit from this research
Good fit: Ideal candidates for this research include infants, particularly those from high-risk populations such as African American and American Indian/Alaska Native infants.
Not a fit: Patients who are older than one year or those without a family history of SIDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of diagnostic tools that identify infants at risk for SIDS, potentially saving lives.
How similar studies have performed: Previous research has shown promise in identifying genetic factors related to SIDS, but this approach utilizing integrative omics is relatively novel.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Hauck, Fern R — University of Virginia
- Study coordinator: Hauck, Fern R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.